Journals / The European Research Journal / 2017 / Cilt: 3 - Sayı: 1

Incidence and risk factors of contrast-induced nephropathy after diagnostic or interventional coronary angiography

Pages
16–24
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In multivariate analysis, age (oddsratio [OR]=1.04; 95% confidence interval [CI], 1.02-1.06; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Contrast-induced nephropathy (CIN) is the third most common cause of acute renal failure thatoccurred in the hospital.
📊
Key Findings & Data:Increased contrast volume and creatinine value are related with CIN.
💡
Conclusion & Impact:In multivariate analysis, age (oddsratio [OR]=1.04; 95% confidence interval [CI], 1.02-1.06; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives. Contrast-induced nephropathy (CIN) is the third most common cause of acute renal failure thatoccurred in the hospital. In Turkey, there is not enough data about the frequency of CIN in cardiologicalinterventions. Increased contrast volume and creatinine value are related with CIN. We also investigated theCIN predictors. Methods. A total of 2604 patients who underwent coronary angiography or percutaneouscoronary intervention (PCI) in our hospital were prospectively evaluated in terms of CIN. The definition ofCIN includes absolute (≥0.5 mg/dl) or relative increase (≥25%) in serum creatinine at 48-72 h after exposureto a contrast agent compared to baseline serum creatinine values. Results. CIN was detected in 13.6% (355patients) of 2604 patients. According to the procedure; CIN rate was 13.3% (280 of 2108 patients) in coronaryangiography, 13.08% (50 of 382 patients) in elective PCI and 21.49% (25 of 114 patients) in primary PCI.Compared with each of these three groups patients, CIN rate was significantly higher in primary PCI groupthan coronary angiography (p=0.009) and elective PCI (p=0.02) groups. In multivariate analysis, age (oddsratio [OR]=1.04; 95% confidence interval [CI], 1.02-1.06; p

🔖

Cite This Article

BOZAT, T., MELEK, M., ARİ, H., ARİ, S., CETİNKAYA, A. S., DOGANAY, K., COSAR, S. O., EMLEK, N., CELİLOGLU, N., AYDİN, C. (2022). Incidence and risk factors of contrast-induced nephropathy after diagnostic or interventional coronary angiography. The European Research Journal, Cilt: 3 - Sayı: 1, 16–24. https://ajindex.com/articles/594303

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Lakhal K, Ehrmann S, Chaari A, Laissy JP, Regnier B, Wolff M, et al. Acute Kidney Injury Network definition of contrastinduced nephropathy in the critically ill: incidence and outcome. J Crit Care 2011;26:593-9
  2. Finn WF. The clinical and renal consequences of contrastinduced nephropathy. Nephrol Dial Transplant 2006;21[Suppl 1]: i2–i10
  3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
  4. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-9
  5. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64
  6. Lekston A, Kurek A, Tynior B. Impaired renal function in acute myocardial infarction. Cardiol J 2009;16:400-6
  7. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9
  8. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004;93:1515-9
  9. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44:1780-5
  10. Kohli HS, Bhaskaran MC, Muthukumar T. Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant 2000;15:212-7
  11. Hall KA, Wong RW, Hunter GC, Camazine BM, Rappaport WA, Smyth SH, et al. Contrast- induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 1992;53:317-20
  12. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989;320:143-9
  13. Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ, et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: The RAPPID Study. J Am Coll Cardiol 2003;41:2114-8